This AACR pre-conference planner lists the 150 DDR-relevant abstracts in order of presentation, categorized separately by clinical trial and preclinical drug data.
This planner also contains links to each abstract, and the associated trial or drug page on Beacon.
The AACR post-conference report lists all 150 DDR-relevant abstracts presented at the conference along with some additional abstract analysis by asset, target and phase.
The report includes all preclinical abstracts, along with summaries, and all clinical abstracts, with results and safety results. All abstracts include links to the abstracts online and the relevant Beacon drug or trial records.
DDR: AACR Annual Meeting 2023 Abstracts
DDR Webinar March 2023
The 2022 DDR Landscape Review
Find out more
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
Speak with our Team
Our dedicated account and research teams can help you with questions by showing you how this insight and data is collated on Beacon.